STOCK TITAN

[Form 4] RadNet, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

On 09/09/2025, Cornelis Wesdorp, President & CEO, Digital Health at RadNet, Inc. (RDNT) reported a sale of 500 shares of the issuer's common stock at a price of $71.99 per share. After this transaction Wesdorp beneficially owned 53,995 shares directly. The Form 4 was signed by an attorney-in-fact on 09/10/2025. No derivative transactions or additional explanatory details were provided.

Il 09/09/2025 Cornelis Wesdorp, Presidente e CEO, Digital Health di RadNet, Inc. (RDNT) ha comunicato la vendita di 500 azioni del capitale ordinario dell'emittente al prezzo di $71.99 per azione. Dopo l'operazione Wesdorp deteneva direttamente beneficiariamente 53.995 azioni. Il Modulo 4 è stato firmato da un procuratore il 09/10/2025. Non sono state riportate operazioni su strumenti derivati né ulteriori dettagli esplicativi.

El 09/09/2025 Cornelis Wesdorp, Presidente y CEO de Digital Health en RadNet, Inc. (RDNT) informó la venta de 500 acciones de las acciones ordinarias de la emisora a un precio de $71.99 por acción. Tras esta transacción Wesdorp poseía de forma directa y beneficiosa 53.995 acciones. El Formulario 4 fue firmado por un apoderado el 09/10/2025. No se proporcionaron transacciones sobre derivados ni detalles adicionales.

2025-09-09에 RadNet, Inc.(RDNT) 디지털 헬스 부문 회장 겸 CEO인 Cornelis Wesdorp가 발행회사의 보통주 500주를 주당 $71.99에 매도했다고 보고했습니다. 이 거래 후 Wesdorp는 직접적으로 53,995주를 실질 보유하고 있었습니다. Form 4는 2025-09-10에 대리인에 의해 서명되었습니다. 파생상품 거래나 추가 설명은 제공되지 않았습니다.

Le 09/09/2025, Cornelis Wesdorp, Président et CEO, Digital Health chez RadNet, Inc. (RDNT) a déclaré la vente de 500 actions des actions ordinaires de l'émetteur au prix de 71,99 $ par action. Après cette transaction, Wesdorp détenait directement à titre bénéficiaire 53 995 actions. Le formulaire 4 a été signé par un mandataire le 10/09/2025. Aucune opération sur dérivés ni aucun détail supplémentaire n'ont été fournis.

Am 09.09.2025 meldete Cornelis Wesdorp, President & CEO, Digital Health bei RadNet, Inc. (RDNT), den Verkauf von 500 Aktien der Stammaktien des Emittenten zu einem Preis von $71.99 je Aktie. Nach dieser Transaktion besaß Wesdorp direkt wirtschaftlich 53.995 Aktien. Das Formular 4 wurde am 10.09.2025 von einem Bevollmächtigten unterschrieben. Es wurden keine Derivatgeschäfte oder zusätzlichen erläuternden Angaben gemacht.

Positive
  • Continued substantial ownership: Reporting person retains 53,995 shares following the sale, indicating ongoing insider alignment with shareholders.
Negative
  • Insider sale: Disposal of 500 shares at $71.99 reduces the executive's direct holding, though the amount is small relative to total ownership.

Insights

TL;DR: Routine insider sale by a named executive; ownership remains substantial.

The reported disposal of 500 shares appears to be a small, routine sale relative to the post-transaction holding of 53,995 shares. Such transactions are common for liquidity or diversification and do not, by themselves, indicate governance concerns. The filing contains no indication the sale was part of a Rule 10b5-1 plan or linked to any material corporate event, and no derivatives or additional dispositions were disclosed.

TL;DR: Minor insider sale; impact on market or control is negligible.

The 500-share sale at $71.99 represents a small percentage of the executive's remaining holding and is unlikely to affect share supply or signal a material shift in insider conviction. The report provides clear transaction price and post-sale ownership but lacks context such as purpose of sale or whether proceeds were redeployed, limiting deeper interpretation.

Il 09/09/2025 Cornelis Wesdorp, Presidente e CEO, Digital Health di RadNet, Inc. (RDNT) ha comunicato la vendita di 500 azioni del capitale ordinario dell'emittente al prezzo di $71.99 per azione. Dopo l'operazione Wesdorp deteneva direttamente beneficiariamente 53.995 azioni. Il Modulo 4 è stato firmato da un procuratore il 09/10/2025. Non sono state riportate operazioni su strumenti derivati né ulteriori dettagli esplicativi.

El 09/09/2025 Cornelis Wesdorp, Presidente y CEO de Digital Health en RadNet, Inc. (RDNT) informó la venta de 500 acciones de las acciones ordinarias de la emisora a un precio de $71.99 por acción. Tras esta transacción Wesdorp poseía de forma directa y beneficiosa 53.995 acciones. El Formulario 4 fue firmado por un apoderado el 09/10/2025. No se proporcionaron transacciones sobre derivados ni detalles adicionales.

2025-09-09에 RadNet, Inc.(RDNT) 디지털 헬스 부문 회장 겸 CEO인 Cornelis Wesdorp가 발행회사의 보통주 500주를 주당 $71.99에 매도했다고 보고했습니다. 이 거래 후 Wesdorp는 직접적으로 53,995주를 실질 보유하고 있었습니다. Form 4는 2025-09-10에 대리인에 의해 서명되었습니다. 파생상품 거래나 추가 설명은 제공되지 않았습니다.

Le 09/09/2025, Cornelis Wesdorp, Président et CEO, Digital Health chez RadNet, Inc. (RDNT) a déclaré la vente de 500 actions des actions ordinaires de l'émetteur au prix de 71,99 $ par action. Après cette transaction, Wesdorp détenait directement à titre bénéficiaire 53 995 actions. Le formulaire 4 a été signé par un mandataire le 10/09/2025. Aucune opération sur dérivés ni aucun détail supplémentaire n'ont été fournis.

Am 09.09.2025 meldete Cornelis Wesdorp, President & CEO, Digital Health bei RadNet, Inc. (RDNT), den Verkauf von 500 Aktien der Stammaktien des Emittenten zu einem Preis von $71.99 je Aktie. Nach dieser Transaktion besaß Wesdorp direkt wirtschaftlich 53.995 Aktien. Das Formular 4 wurde am 10.09.2025 von einem Bevollmächtigten unterschrieben. Es wurden keine Derivatgeschäfte oder zusätzlichen erläuternden Angaben gemacht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wesdorp Cornelis

(Last) (First) (Middle)
C/O RADNET, INC.
1510 COTNER AVENUE

(Street)
LOS ANGELES CA 90025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RadNet, Inc. [ RDNT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Pres & CEO, Digital Health
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/09/2025 S 500 D $71.99 53,995 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Jose Gamez, Attorney-in-Fact 09/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Form 4 for RDNT report?

The Form 4 reports a sale of 500 shares of RadNet common stock on 09/09/2025 at $71.99 per share.

Who is the reporting person on this Form 4 for RDNT?

The reporting person is Cornelis Wesdorp, listed as President & CEO, Digital Health, and a director of RadNet, Inc.

How many shares did the insider own after the reported transaction?

After the sale the insider beneficially owned 53,995 shares of RadNet common stock.

Did the Form 4 disclose any derivative transactions or 10b5-1 plan?

No derivative transactions were reported and the filing does not indicate the sale was made pursuant to a Rule 10b5-1 plan.

Who signed the Form 4?

The Form 4 was signed by an attorney-in-fact, /s/ Jose Gamez, on 09/10/2025.
Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

5.49B
66.88M
12.73%
94.2%
7.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES